CARDLYTICS INC (CDLX) Fundamental Analysis & Valuation

NASDAQ:CDLX • US14161W1053

Current stock price

1.13 USD
+0.13 (+13%)
At close:
1.13 USD
0 (0%)
After Hours:

This CDLX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. CDLX Profitability Analysis

1.1 Basic Checks

  • In the past year CDLX has reported negative net income.
  • CDLX had a positive operating cash flow in the past year.
  • In the past 5 years CDLX always reported negative net income.
  • In the past 5 years CDLX reported 4 times negative operating cash flow.
CDLX Yearly Net Income VS EBIT VS OCF VS FCFCDLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M -400M

1.2 Ratios

  • CDLX has a Return On Assets of -36.23%. This is in the lower half of the industry: CDLX underperforms 76.92% of its industry peers.
Industry RankSector Rank
ROA -36.23%
ROE N/A
ROIC N/A
ROA(3y)-35.97%
ROA(5y)-37.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CDLX Yearly ROA, ROE, ROICCDLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K 1.5K

1.3 Margins

  • The Gross Margin of CDLX (55.87%) is better than 68.13% of its industry peers.
  • In the last couple of years the Gross Margin of CDLX has grown nicely.
  • The Profit Margin and Operating Margin are not available for CDLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y5.08%
CDLX Yearly Profit, Operating, Gross MarginsCDLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CDLX Health Analysis

2.1 Basic Checks

  • CDLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CDLX has more shares outstanding
  • Compared to 5 years ago, CDLX has more shares outstanding
  • CDLX has a worse debt/assets ratio than last year.
CDLX Yearly Shares OutstandingCDLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CDLX Yearly Total Debt VS Total AssetsCDLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • Based on the Altman-Z score of -6.25, we must say that CDLX is in the distress zone and has some risk of bankruptcy.
  • CDLX's Altman-Z score of -6.25 is on the low side compared to the rest of the industry. CDLX is outperformed by 84.62% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.25
ROIC/WACCN/A
WACC6.3%
CDLX Yearly LT Debt VS Equity VS FCFCDLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • CDLX has a Current Ratio of 1.75. This is a normal value and indicates that CDLX is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.75, CDLX is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • A Quick Ratio of 1.75 indicates that CDLX should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.75, CDLX is doing good in the industry, outperforming 72.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
CDLX Yearly Current Assets VS Current LiabilitesCDLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CDLX Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.56% over the past year.
  • Looking at the last year, CDLX shows a very negative growth in Revenue. The Revenue has decreased by -16.18% in the last year.
  • CDLX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.53% yearly.
EPS 1Y (TTM)2.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.31%
Revenue 1Y (TTM)-16.18%
Revenue growth 3Y-7.89%
Revenue growth 5Y4.53%
Sales Q2Q%-24.19%

3.2 Future

  • The Earnings Per Share is expected to grow by 46.09% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, CDLX will show a very negative growth in Revenue. The Revenue will decrease by -12.96% on average per year.
EPS Next Y16.79%
EPS Next 2Y46.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-24.98%
Revenue Next 2Y-12.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CDLX Yearly Revenue VS EstimatesCDLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
CDLX Yearly EPS VS EstimatesCDLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

1

4. CDLX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CDLX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CDLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CDLX Price Earnings VS Forward Price EarningsCDLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CDLX Per share dataCDLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CDLX's earnings are expected to grow with 46.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.09%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CDLX Dividend Analysis

5.1 Amount

  • No dividends for CDLX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CDLX Fundamentals: All Metrics, Ratios and Statistics

CARDLYTICS INC

NASDAQ:CDLX (4/2/2026, 8:12:38 PM)

After market: 1.13 0 (0%)

1.13

+0.13 (+13%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-04
Earnings (Next)05-05
Inst Owners40.66%
Inst Owner Change-5.26%
Ins Owners2.11%
Ins Owner Change7.28%
Market Cap62.21M
Revenue(TTM)233.27M
Net Income(TTM)-103.49M
Analysts48
Price Target1.06 (-6.19%)
Short Float %13.83%
Short Ratio7.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)98.13%
Min EPS beat(2)54.25%
Max EPS beat(2)142.02%
EPS beat(4)4
Avg EPS beat(4)57.32%
Min EPS beat(4)11.45%
Max EPS beat(4)142.02%
EPS beat(8)7
Avg EPS beat(8)46.45%
EPS beat(12)11
Avg EPS beat(12)56.16%
EPS beat(16)14
Avg EPS beat(16)45.2%
Revenue beat(2)1
Avg Revenue beat(2)-2.5%
Min Revenue beat(2)-5.99%
Max Revenue beat(2)1%
Revenue beat(4)2
Avg Revenue beat(4)-0.91%
Min Revenue beat(4)-5.99%
Max Revenue beat(4)4.5%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)5
Avg Revenue beat(12)0.62%
Revenue beat(16)6
Avg Revenue beat(16)0.05%
PT rev (1m)-36.15%
PT rev (3m)-36.15%
EPS NQ rev (1m)-58.02%
EPS NQ rev (3m)-58.02%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-23.61%
Revenue NQ rev (3m)-24.7%
Revenue NY rev (1m)-20.66%
Revenue NY rev (3m)-22.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF 6.7
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.38
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)0.17
OCFY14.93%
SpS4.24
BVpS-0.12
TBVpS-2.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -36.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.87%
FCFM N/A
ROA(3y)-35.97%
ROA(5y)-37.08%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.29%
GM growth 5Y5.08%
F-Score6
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 62.52%
Cap/Sales 6.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z -6.25
F-Score6
WACC6.3%
ROIC/WACCN/A
Cap/Depr(3y)61.49%
Cap/Depr(5y)52.49%
Cap/Sales(3y)5.9%
Cap/Sales(5y)5.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.31%
EPS Next Y16.79%
EPS Next 2Y46.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.18%
Revenue growth 3Y-7.89%
Revenue growth 5Y4.53%
Sales Q2Q%-24.19%
Revenue Next Year-24.98%
Revenue Next 2Y-12.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year184.56%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y205.28%
OCF growth 3YN/A
OCF growth 5YN/A

CARDLYTICS INC / CDLX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CARDLYTICS INC?

ChartMill assigns a fundamental rating of 1 / 10 to CDLX.


Can you provide the valuation status for CARDLYTICS INC?

ChartMill assigns a valuation rating of 1 / 10 to CARDLYTICS INC (CDLX). This can be considered as Overvalued.


Can you provide the profitability details for CARDLYTICS INC?

CARDLYTICS INC (CDLX) has a profitability rating of 1 / 10.